Summary:
Currently, a clinical research study is ongoing to assess how well an investigational medication keeps giant cell arteritis from returning once prednisone has been stopped.
Participation in this study would last approximately 3 years and would include at least 27 visits to our office.
Qualified Participants Must:
• Be 50 years of age or older
•
Currently have active Giant Cell Arteritis
•
Have no history of Hepatitis B, C, or HIV
Qualified Participants May Receive:
Study medication and study-related care for giant cell arteritis. Reimbursement may be provided up to $50 a visit for time and travel.